$1.03
-0.04-3.74%
At close: -
$1.02
-0.01-0.97%
After Hours: 4:09 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Nektar Therapeutics in recent months.
Browse guidance and forecast on all stocks.